Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T61731 |
PPARγ agonist 4
|
||
PPARγ agonist 4 (Compound 18b), a potent and selective PPARγ agonist, demonstrates antitumor efficacy only when used in conjunction with Imatinib. Notably, PPARγ agonist 4 does not exhibit cytotoxic effects on either non-resistant or resistant cells [1]. |